CovidChloroV1, Main, Corpus, bibRecord, 001805

Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.

Identifieur interne : 001805 ( Main/Corpus ); précédent : 001804; suivant : 001806

Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.

Auteurs : Mauro Grandolfo ; Paolo Romita ; Domenico Bonamonte ; Gerardo Cazzato ; Katharina Hansel ; Luca Stingeni ; Claudio Conforti ; Roberta Giuffrida ; Caterina Foti

Source :

Dermatologic therapy [ 1529-8019 ] ; 2020.

RBID : pubmed:32362051

English descriptors

KwdEn :
- Aged (MeSH), Antimalarials (adverse effects), Betacoronavirus (MeSH), COVID-19 (MeSH), Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Drug Hypersensitivity Syndrome (diagnosis), Drug Hypersensitivity Syndrome (etiology), Eosinophilia (chemically induced), Eosinophilia (diagnosis), Female (MeSH), Humans (MeSH), Hydroxychloroquine (adverse effects), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Pneumonia, Viral (epidemiology), SARS-CoV-2 (MeSH).
MESH :
- chemical , adverse effects : Antimalarials, Hydroxychloroquine.
- chemically induced : Eosinophilia.
- diagnosis : Drug Hypersensitivity Syndrome, Eosinophilia.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- etiology : Drug Hypersensitivity Syndrome.
- Aged, Betacoronavirus, COVID-19, Female, Humans, Pandemics, SARS-CoV-2.

DOI: 10.1111/dth.13499
PubMed: 32362051
PubMed Central: PMC7267636

Links to Exploration step

pubmed:32362051

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.</title>
<author><name sortKey="Grandolfo, Mauro" sort="Grandolfo, Mauro" uniqKey="Grandolfo M" first="Mauro" last="Grandolfo">Mauro Grandolfo</name>
<affiliation><nlm:affiliation>Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Romita, Paolo" sort="Romita, Paolo" uniqKey="Romita P" first="Paolo" last="Romita">Paolo Romita</name>
<affiliation><nlm:affiliation>Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bonamonte, Domenico" sort="Bonamonte, Domenico" uniqKey="Bonamonte D" first="Domenico" last="Bonamonte">Domenico Bonamonte</name>
<affiliation><nlm:affiliation>Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cazzato, Gerardo" sort="Cazzato, Gerardo" uniqKey="Cazzato G" first="Gerardo" last="Cazzato">Gerardo Cazzato</name>
<affiliation><nlm:affiliation>Pathology Unit, Department of Emergency and Organ Transplantations, University of Bari, Bari, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hansel, Katharina" sort="Hansel, Katharina" uniqKey="Hansel K" first="Katharina" last="Hansel">Katharina Hansel</name>
<affiliation><nlm:affiliation>Dermatology Section, Department of Medicine, University of Perugia, Perugia, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Stingeni, Luca" sort="Stingeni, Luca" uniqKey="Stingeni L" first="Luca" last="Stingeni">Luca Stingeni</name>
<affiliation><nlm:affiliation>Dermatology Section, Department of Medicine, University of Perugia, Perugia, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Conforti, Claudio" sort="Conforti, Claudio" uniqKey="Conforti C" first="Claudio" last="Conforti">Claudio Conforti</name>
<affiliation><nlm:affiliation>Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Giuffrida, Roberta" sort="Giuffrida, Roberta" uniqKey="Giuffrida R" first="Roberta" last="Giuffrida">Roberta Giuffrida</name>
<affiliation><nlm:affiliation>Department of Clinical and Experimental Medicine, Dermatology, University of Messina, Messina, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Foti, Caterina" sort="Foti, Caterina" uniqKey="Foti C" first="Caterina" last="Foti">Caterina Foti</name>
<affiliation><nlm:affiliation>Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32362051</idno>
<idno type="pmid">32362051</idno>
<idno type="doi">10.1111/dth.13499</idno>
<idno type="pmc">PMC7267636</idno>
<idno type="wicri:Area/Main/Corpus">001805</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001805</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.</title>
<author><name sortKey="Grandolfo, Mauro" sort="Grandolfo, Mauro" uniqKey="Grandolfo M" first="Mauro" last="Grandolfo">Mauro Grandolfo</name>
<affiliation><nlm:affiliation>Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Romita, Paolo" sort="Romita, Paolo" uniqKey="Romita P" first="Paolo" last="Romita">Paolo Romita</name>
<affiliation><nlm:affiliation>Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bonamonte, Domenico" sort="Bonamonte, Domenico" uniqKey="Bonamonte D" first="Domenico" last="Bonamonte">Domenico Bonamonte</name>
<affiliation><nlm:affiliation>Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cazzato, Gerardo" sort="Cazzato, Gerardo" uniqKey="Cazzato G" first="Gerardo" last="Cazzato">Gerardo Cazzato</name>
<affiliation><nlm:affiliation>Pathology Unit, Department of Emergency and Organ Transplantations, University of Bari, Bari, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hansel, Katharina" sort="Hansel, Katharina" uniqKey="Hansel K" first="Katharina" last="Hansel">Katharina Hansel</name>
<affiliation><nlm:affiliation>Dermatology Section, Department of Medicine, University of Perugia, Perugia, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Stingeni, Luca" sort="Stingeni, Luca" uniqKey="Stingeni L" first="Luca" last="Stingeni">Luca Stingeni</name>
<affiliation><nlm:affiliation>Dermatology Section, Department of Medicine, University of Perugia, Perugia, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Conforti, Claudio" sort="Conforti, Claudio" uniqKey="Conforti C" first="Claudio" last="Conforti">Claudio Conforti</name>
<affiliation><nlm:affiliation>Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Giuffrida, Roberta" sort="Giuffrida, Roberta" uniqKey="Giuffrida R" first="Roberta" last="Giuffrida">Roberta Giuffrida</name>
<affiliation><nlm:affiliation>Department of Clinical and Experimental Medicine, Dermatology, University of Messina, Messina, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Foti, Caterina" sort="Foti, Caterina" uniqKey="Foti C" first="Caterina" last="Foti">Caterina Foti</name>
<affiliation><nlm:affiliation>Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Dermatologic therapy</title>
<idno type="eISSN">1529-8019</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term>
<term>Antimalarials (adverse effects)</term>
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Drug Hypersensitivity Syndrome (diagnosis)</term>
<term>Drug Hypersensitivity Syndrome (etiology)</term>
<term>Eosinophilia (chemically induced)</term>
<term>Eosinophilia (diagnosis)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (adverse effects)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antimalarials</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Eosinophilia</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Drug Hypersensitivity Syndrome</term>
<term>Eosinophilia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Drug Hypersensitivity Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Female</term>
<term>Humans</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32362051</PMID>
<DateCompleted><Year>2020</Year>
<Month>11</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-8019</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>33</Volume>
<Issue>4</Issue>
<PubDate><Year>2020</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Dermatologic therapy</Title>
<ISOAbbreviation>Dermatol Ther</ISOAbbreviation>
</Journal>
<ArticleTitle>Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.</ArticleTitle>
<Pagination><MedlinePgn>e13499</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/dth.13499</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grandolfo</LastName>
<ForeName>Mauro</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Romita</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0002-5559-9722</Identifier>
<AffiliationInfo><Affiliation>Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bonamonte</LastName>
<ForeName>Domenico</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cazzato</LastName>
<ForeName>Gerardo</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Pathology Unit, Department of Emergency and Organ Transplantations, University of Bari, Bari, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hansel</LastName>
<ForeName>Katharina</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Dermatology Section, Department of Medicine, University of Perugia, Perugia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stingeni</LastName>
<ForeName>Luca</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Dermatology Section, Department of Medicine, University of Perugia, Perugia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Conforti</LastName>
<ForeName>Claudio</ForeName>
<Initials>C</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0001-5126-8873</Identifier>
<AffiliationInfo><Affiliation>Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Giuffrida</LastName>
<ForeName>Roberta</ForeName>
<Initials>R</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0002-5492-3033</Identifier>
<AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, Dermatology, University of Messina, Messina, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Foti</LastName>
<ForeName>Caterina</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>05</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Dermatol Ther</MedlineTA>
<NlmUniqueID>9700070</NlmUniqueID>
<ISSNLinking>1396-0296</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D063926" MajorTopicYN="N">Drug Hypersensitivity Syndrome</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004802" MajorTopicYN="N">Eosinophilia</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>11</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32362051</ArticleId>
<ArticleId IdType="doi">10.1111/dth.13499</ArticleId>
<ArticleId IdType="pmc">PMC7267636</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):808-810</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27923648</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Rheumatol. 2020 Mar;16(3):155-166</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32034323</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Drugs Dermatol. 2019 Feb 01;18(2):207-209</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30811149</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Dermatol Ther. 2020 Jul;33(4):e13298</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32157783</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Mol Sci. 2017 Jun 09;18(6):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28598363</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Dermatol Ther. 2020 Jul;33(4):e13437</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32314492</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Dermatol. 2012 Nov-Dec;22(6):799-800</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23137713</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Dermatol Ther. 2020 May;33(3):e13380</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32253799</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001805 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001805 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32362051
   |texte=   Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32362051" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.

Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki